Director/PDMR Shareholding

Eco Animal Health Group PLC

04 December 2025

 

04 December 2025

ECO Animal Health Group plc

("ECO" or the "Company")

Share Purchase by Executive Director

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that on 04 December 2025 David Hallas, Chief Executive Officer, purchased 18,348 ordinary shares in the Company ("Ordinary Shares") at 109 pence per Ordinary Share. Following this, Mr Hallas holds 203,041 Ordinary Shares, representing approximately 0.29 per cent. of the Company's issued share capital.

-Ends-

For further information please contact:

ECO Animal Health Group plc David Hallas (Chief Executive Officer) Christopher Wilks (Chief Financial Officer) 020 8447 8899 ICR Healthcare (Financial PR) Mary-Jane Elliott Jessica Hodgson 020 3709 5700 Singer Capital Markets (Nominated Adviser & Joint Broker) Philip Davies Sam Butcher Samed Ethemi 020 7496 3000 Panmure Liberum (Joint Broker) Emma Earl Will Goode Mark Rogers Rupert Dearden 020 3100 2000  Equity Development Hannah Crowe Matt Evans 020 7065 2692

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. 

Click here for more information: https://ecoanimalhealth.com

PDMR Notification

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	David Hallas
2.	Reason for the notification
a.	Position/status	Chief Executive Officer
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Eco Animal Health Group Plc
b.	LEI	2138009XN9DJ3YP70B55
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 5p each. GB0032036807
b.	Nature of the transaction	Purchase of Ordinary Shares
c.	Price(s) and volume(s)	Price(s) Volume(s) 109p 18,348
d.	Aggregated information Aggregated volume Price	n/a
e.	Date of the transaction	04 December 2025
f.	Place of the transaction	London Stock Exchange

 

END